Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?

CONCLUSION: The present study has found that the use of ACE inh/ARBs therapy might be associated with an increased in-hospital mortality in patients who were diagnosed with Covid-19 pneumonia. It is likely that ACE inh/ARBs therapy might not be beneficial in the subgroup of hypertensive Covid-19 patients despite the fact that there might be the possibility of some unmeasured residual confounders to affect the results of the study. PMID: 32569491 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32569491?dopt=Abstract

Source: Clinical and Experimental Hypertension - June 21, 2020 Category: Cardiology Authors: Selçuk M, Çınar T, Keskin M, Çiçek V, Kılıç Ş, Kenan B, Doğan S, Asal S, Günay N, Yıldırım E, Keskin Ü, Orhan AL Tags: Clin Exp Hypertens Source Type: research